epinephrine
- Product NDC
- 42291-425
- 11-digit product format
- 422910425
- Labeler code
- 42291
- Product ID
- 42291-425_ec6b210b-e84b-d325-e053-2a95a90a3e93
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- epinephrine
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Labeler
- AvKARE
- Application
- NDA020800
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2020-12-07
- Marketing end
- 0000-00-00
- Substance
- EPINEPHRINE
- Active strength
- 0 mg/.3mL
- Pharmacologic classes
- Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42291-425-02 | 42291042502 | 2 SYRINGE, GLASS in 1 CARTON (42291-425-02) > .3 mL in 1 SYRINGE, GLASS | 2020-12-07 | 0000-00-00 | No | No | Current |